MeiraGTx Holdings (MGTX) Income towards Parent Company (2017 - 2025)

MeiraGTx Holdings (MGTX) posted Income towards Parent Company of $15.9 million for Q4 2025, up 132.46% on a QoQ basis from -$49.0 million in Q3 2025, and up 149.36% year-over-year from $6.4 million in Q4 2024.

MeiraGTx Holdings (MGTX) Income towards Parent Company (2017 - 2025) Analysis & Trends

MeiraGTx Holdings' Income towards Parent Company history runs 9 years deep, the most recent figure standing at $15.9 million for Q4 2025.

  • Quarterly Income towards Parent Company rose 149.36% year-over-year to $15.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$122.1 million (up 29.69% YoY) and the FY2025 annual result came in at -$287.2 million, up 7.19% from the prior year.
  • Income towards Parent Company was $15.9 million for Q4 2025 at MeiraGTx Holdings, up from -$49.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $15.9 million in Q4 2025 and bottomed at -$51.0 million in Q2 2024.
  • A 5-year average of -$29.3 million and a median of -$31.8 million in 2023 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 927.97% — and 2025, when it soared 149.36%.
  • MeiraGTx Holdings' Income towards Parent Company stood at -$4.3 million in 2021, then plunged by 927.97% to -$44.0 million in 2022, then soared by 114.9% to $6.5 million in 2023, then slumped by 591.63% to -$32.2 million in 2024, then surged by 149.36% to $15.9 million in 2025.
  • Business Quant data shows MGTX's Income towards Parent Company at $15.9 million in Q4 2025, -$49.0 million in Q3 2025, and -$41.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 MeiraGTx Holdings 997.33 Mn 931.40 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 15.89 Mn
Sep 30, 2025 -48.96 Mn
Jun 30, 2025 -41.42 Mn
Mar 31, 2025 -47.63 Mn
Dec 31, 2024 -32.20 Mn
Sep 30, 2024 -41.50 Mn
Jun 30, 2024 -51.05 Mn
Mar 31, 2024 -48.93 Mn
Dec 31, 2023 6.55 Mn
Sep 30, 2023 -35.62 Mn
Jun 30, 2023 -31.49 Mn
Mar 31, 2023 -34.28 Mn
Dec 31, 2022 -43.96 Mn
Sep 30, 2022 -24.41 Mn
Jun 30, 2022 -25.08 Mn
Mar 31, 2022 -30.09 Mn
Dec 31, 2021 -4.28 Mn
Sep 30, 2021 -23.75 Mn
Jun 30, 2021 -21.67 Mn
Mar 31, 2021 -23.13 Mn